Tauns Laboratories (TSE:197A) Common Stock: 円392 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:197A Tauns Laboratories Inc TSE:197A
15 GF Score
Price 円482.00
! 6 Warning Signs
View Full Analysis

What is Tauns Laboratories Common Stock?

Tauns Laboratories TSE:197A +1.90% 15 Common Stock is 円392 Mil as of Dec. 2025. GuruFocus rates TSE:197A with a GF Score™ of 15/100. The stock has 6 warning signs investors should review.

Tauns Laboratories's quarterly common stock increased from Jun. 2025 (円290 Mil) to Sep. 2025 (円296 Mil) and increased from Sep. 2025 (円296 Mil) to Dec. 2025 (円392 Mil).

Tauns Laboratories's annual common stock increased from Jun. 2023 (円100 Mil) to Jun. 2024 (円200 Mil) and increased from Jun. 2024 (円200 Mil) to Jun. 2025 (円290 Mil).

Tauns Laboratories Common Stock Historical Data

* Premium members only.

The historical data trend for Tauns Laboratories's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tauns Laboratories Common Stock Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Common Stock
100.00 100.00 200.00 289.77

Tauns Laboratories Quarterly Data
Jun22 Jun23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only 271.73 289.77 296.35 392.12 393.64
TSE:197A
15GF Score
Tauns Laboratories Inc TSE:197A
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tauns Laboratories Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of 円392 Mil mean?
Tauns Laboratories (TSE:197A) has a Common Stock of 円392 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Tauns Laboratories and its competitors.
Is Tauns Laboratories' Common Stock too high?
Tauns Laboratories' current Common Stock is 円392 Mil. Overall, Tauns Laboratories has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Tauns Laboratories' Common Stock compare to ISRG and BDX?
Tauns Laboratories' Common Stock of 円392 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Tauns Laboratories and its competitors. Tauns Laboratories's current Common Stock is 円392 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tauns Laboratories stock overvalued right now?
Tauns Laboratories (TSE:197A) has a current Common Stock of 円392 Mil. The current Common Stock is 円392 Mil. Tauns Laboratories' overall GF Score™ is 15/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Tauns Laboratories (TSE:197A), the current Common Stock is 円392 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tauns Laboratories Business Description

Address 761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.
15GF Score

Get the complete analysis for TSE:197A

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円482.00
Price